Lavender Aromatherapy on Sleep Quality and Metabolic Parameters of Type 2 Diabetic Patients With Insomnia

• Status: Completed
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed as cross-over double-blind placebo-controlled randomized clinical trial that 40 diabetic patients with sleep disorder with the inclusion criteria will enter into the study and randomly assign to first intervention and first placebo groups.The primary outcomes are change in sleep disorder and metabolic parameters that will be evaluated at the end of the study.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shiraz University of Medical Sciences

Criteria

Inclusion Criteria:

• Diabetes mellitus type 2

• Age between 25-65 years old

• Fasting Blood Sugar between 70-130

• 2 hour post prandial glucose less than 180.

• HbA1C less than 7

• Sleep disorder according to pittsburgh Insomnia Rating Scale more than 5.

Exclusion Criteria:

• Any systemic illnesses

• Use of sedative or antidepressant drugs

• Pregnancy

• Lactation

• History of allergic reaction to Lavender

• History of allergic rhinitis, asthma and respiratory disorders

• Anosmia

• Headache that start with smell

• Cigarette smocking or substance abuse

• Hospitalization or surgery within 1 months ago.

• Work shift